UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Endometrial cancer: A society of gynecologic oncology evidence-based review and recommendations

Gynecologic oncology, 2021-03, Vol.160 (3), p.817-826

2021

Volltextzugriff (PDF)

Clinicopathologic Significance of Mismatch Repair Defects in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study

Journal of clinical oncology, 2016-09, Vol.34 (25), p.3062-3068

2016

Volltextzugriff (PDF)

Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations

American journal of obstetrics and gynecology, 2011-06, Vol.204 (6), p.466-478

2011

Volltextzugriff (PDF)

Endometrial cancer: A society of gynecologic oncology evidence-based review and recommendations, part II

Gynecologic oncology, 2021-03, Vol.160 (3), p.827-834

2021

Volltextzugriff (PDF)

Non-surgical management of recurrent Paget’s disease of the vulva: A case report

Gynecologic oncology reports, 2024-10, Vol.55, p.101511, Article 101511

2024

Volltextzugriff (PDF)

Expression of microRNAs and their target genes in melanomas originating from gynecologic sites

PloS one, 2023-06, Vol.18 (6), p.e0285804-e0285804

2023

Volltextzugriff (PDF)

Surgical-pathological findings in type 1 and 2 endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study on GOG-210 protocol

Gynecologic oncology, 2017-06, Vol.145 (3), p.519-525

2017

Volltextzugriff (PDF)

A pilot study of topical imiquimod therapy for the treatment of recurrent extramammary Paget's disease

Gynecologic oncology, 2016-07, Vol.142 (1), p.139-143

2016

Volltextzugriff (PDF)

Epigenetic MMR defect identifies a risk group not accounted for through traditional risk stratification algorithms in endometrial cancer

Frontiers in oncology, 2023-04, Vol.13, p.1147657-1147657

2023

Volltextzugriff (PDF)

Salpingectomy, why not?

American journal of obstetrics and gynecology, 2014-05, Vol.210 (5), p.385-386

Backes, Floor J., MD

2014

Volltextzugriff (PDF)

Evaluating the efficacy of enzalutamide and the development of resistance in a preclinical mouse model of type-I endometrial carcinoma

Neoplasia (New York, N.Y.), 2020-10, Vol.22 (10), p.484-496

2020

Volltextzugriff (PDF)

Acute worsening of dermatomyositis after initiation of PARP inhibitor therapy in two women with advanced ovarian malignancy

Gynecologic oncology reports, 2021-11, Vol.38, p.100872, Article 100872

2021

Volltextzugriff (PDF)

Translational randomized phase II trial of cabozantinib in combination with nivolumab in advanced, recurrent, or metastatic endometrial cancer

Journal for immunotherapy of cancer, 2022-03, Vol.10 (3), p.e004233

2022

Volltextzugriff (PDF)

Less radical surgery for early-stage cervical cancer: Can conization specimens help identify patients at low risk for parametrial involvement?

Gynecologic oncology, 2017-02, Vol.144 (2), p.290-293

2017

Volltextzugriff (PDF)

The Adrenal Gland as a Sanctuary Site of Metastases After Pembrolizumab Treatment: A Case Series

Journal of the National Comprehensive Cancer Network, 2018-11, Vol.16 (11), p.1279-1283

2018

Volltextzugriff (PDF)

Sparse feature selection for classification and prediction of metastasis in endometrial cancer

BMC genomics, 2017-03, Vol.18 (Suppl 3), p.233-233, Article 233

2017

Volltextzugriff (PDF)

Combination lenvatinib plus pembrolizumab in the treatment of ovarian clear cell carcinoma: A case series

Gynecologic oncology reports, 2023-04, Vol.46, p.101171, Article 101171

2023

Volltextzugriff (PDF)

Sentinel lymph node mapping and staging in endometrial cancer: A Society of Gynecologic Oncology literature review with consensus recommendations

Gynecologic oncology, 2017-08, Vol.146 (2), p.405-415

2017

Volltextzugriff (PDF)

Gynecologic Cancer InterGroup (GCIG) Consensus Review for Uterine Serous Carcinoma

International journal of gynecological cancer, 2014-11, Vol.24 (9 Suppl 3), p.S83-S89

2014

Volltextzugriff (PDF)

Pathologic chemotherapy response score in epithelial ovarian cancer: Surgical, genetic, and survival considerations

Surgical oncology, 2020-09, Vol.34, p.40-45

2020

Volltextzugriff (PDF)

Use of the Khorana score to predict venous thromboembolism in patients undergoing chemotherapy for uterine cancer

Gynecologic oncology reports, 2023-04, Vol.46, p.101156-101156, Article 101156

2023

Volltextzugriff (PDF)

Perioperative Outcomes for Laparotomy Compared to Robotic Surgical Staging of Endometrial Cancer in the Elderly: A Retrospective Cohort

International journal of gynecological cancer, 2016-11, Vol.26 (9), p.1717-1721

2016

Volltextzugriff (PDF)

Recurrence rate in early-stage epithelial ovarian cancer: Is there a role for upfront maintenance with PARP inhibitors in stages I and II?

Gynecologic oncology reports, 2023-04, Vol.46, p.101173-101173, Article 101173

2023

Volltextzugriff (PDF)

Prospective evaluation of DNA mismatch repair protein expression in primary endometrial cancer

Gynecologic oncology, 2009-09, Vol.114 (3), p.486-490

2009

Volltextzugriff (PDF)

1 – 25 von 154

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(146)
Mit Volltextzugriff
(126)

Publikationsform

Sprache

Englisch
(154)

Erscheinungsjahr

n.n

Thema

Science & Technology
(112)
Life Sciences & Biomedicine
(111)
Female
(88)
Humans
(87)
Oncology
(87)
Obstetrics & Gynecology
(77)
Middle Aged
(55)
Endometrial Cancer
(47)
Aged
(42)
Retrospective Studies
(35)
Adult
(30)
Neoplasm Staging
(30)
Obstetrics And Gynecology
(30)
Endometrial Neoplasms - Pathology
(26)
Hematology, Oncology And Palliative Medicine
(24)
Ovarian Cancer
(21)
Prognosis
(20)
Aged, 80 And Over
(17)
Chemotherapy
(17)
Ovarian Neoplasms - Drug Therapy
(17)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Endometrial cancer: A society of gynecologic oncology evidence-based review and recommendations

Clinicopathologic Significance of Mismatch Repair Defects in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study

Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations

Endometrial cancer: A society of gynecologic oncology evidence-based review and recommendations, part II

Non-surgical management of recurrent Paget’s disease of the vulva: A case report

Expression of microRNAs and their target genes in melanomas originating from gynecologic sites

Surgical-pathological findings in type 1 and 2 endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study on GOG-210 protocol

A pilot study of topical imiquimod therapy for the treatment of recurrent extramammary Paget's disease

Epigenetic MMR defect identifies a risk group not accounted for through traditional risk stratification algorithms in endometrial cancer

Salpingectomy, why not?

Evaluating the efficacy of enzalutamide and the development of resistance in a preclinical mouse model of type-I endometrial carcinoma

Acute worsening of dermatomyositis after initiation of PARP inhibitor therapy in two women with advanced ovarian malignancy

Translational randomized phase II trial of cabozantinib in combination with nivolumab in advanced, recurrent, or metastatic endometrial cancer

Less radical surgery for early-stage cervical cancer: Can conization specimens help identify patients at low risk for parametrial involvement?

The Adrenal Gland as a Sanctuary Site of Metastases After Pembrolizumab Treatment: A Case Series

Sparse feature selection for classification and prediction of metastasis in endometrial cancer

Combination lenvatinib plus pembrolizumab in the treatment of ovarian clear cell carcinoma: A case series

Sentinel lymph node mapping and staging in endometrial cancer: A Society of Gynecologic Oncology literature review with consensus recommendations

Gynecologic Cancer InterGroup (GCIG) Consensus Review for Uterine Serous Carcinoma

Pathologic chemotherapy response score in epithelial ovarian cancer: Surgical, genetic, and survival considerations

Use of the Khorana score to predict venous thromboembolism in patients undergoing chemotherapy for uterine cancer

Randomized Phase II Trial of Carboplatin-Paclitaxel Compared with Carboplatin-Paclitaxel-Trastuzumab in Advanced (Stage III-IV) or Recurrent Uterine Serous Carcinomas that Overexpress Her2/Neu (NCT01367002): Updated Overall Survival Analysis

Perioperative Outcomes for Laparotomy Compared to Robotic Surgical Staging of Endometrial Cancer in the Elderly: A Retrospective Cohort

Recurrence rate in early-stage epithelial ovarian cancer: Is there a role for upfront maintenance with PARP inhibitors in stages I and II?

Prospective evaluation of DNA mismatch repair protein expression in primary endometrial cancer

Suchergebnisse filtern